Searchable abstracts of presentations at key conferences in endocrinology

ea0010p18 | Clinical case reports/Governance | SFE2005

A charcot joint without evidence of a clinical neuropathy

Patel D , Hameed A , Mehta S , Gabriel C , Rosenfeld P , Earnest L , Hogg D , Valabhji J

The Charcot joint was originally described as tabetic arthopathy and published in 1868. This occurs in approximately 0.2% of people with diabetes and usually involves a prior peripheral neuropathy. Other factors involved in the pathogenesis of this osteoarthropathy are autonomic neuropathy & trauma.A 74-year-old male presented in August 2004 with a subacute history of right foot swelling & discomfort. There was no discreet history of preceding tr...

ea0098c33 | Clinical – Nuclear Medicine/Interventional Radiology/Imaging | NANETS2023

DOTATATE PET/CT imaging in prostate cancer: incidental observations and potential future implications

E Salem MD, PhD Ahmed , Soares MD Heloisa P. , Fine MD Gabriel C , Morton MD. Kathryn A

Background: Hormonally-refractory, lethal forms of PCa may express neuroendocrine features, including PCa with neuroendocrine differentiation (NEDPCa) and treatment emergent small cell neuroendocrine PCa (tSCNC). We hypothesize that some lethal metastatic PCa may show higher expression of SSTR than of PSMA and that a dual imaging approach with PET radiopharmaceuticals targeting these moieties will enable informed selection of patients for the future corresponding therapeutic r...